Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

An isoquinoline alkaloid from the Chinese herbal plant Corydalis yanhusuo W.T. Wang inhibits P-glycoprotein and multidrug resistance-associate protein 1.

Lei Y, Tan J, Wink M, Ma Y, Li N, Su G.

Food Chem. 2013 Feb 15;136(3-4):1117-21. doi: 10.1016/j.foodchem.2012.09.059. Epub 2012 Sep 28.

PMID:
23194502
[PubMed - indexed for MEDLINE]
2.

Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.

Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV.

Mol Cell Biochem. 2007 Feb;296(1-2):85-95. Epub 2006 Sep 8.

PMID:
16960658
[PubMed - indexed for MEDLINE]
3.

Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells.

Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y.

Phytomedicine. 2011 Dec 15;19(1):83-7. doi: 10.1016/j.phymed.2011.06.031. Epub 2011 Jul 29.

PMID:
21802927
[PubMed - indexed for MEDLINE]
4.

Reversal of multidrug resitance by natural substances from plants.

Molnár J, Engi H, Hohmann J, Molnár P, Deli J, Wesolowska O, Michalak K, Wang Q.

Curr Top Med Chem. 2010;10(17):1757-68. Review.

PMID:
20645919
[PubMed - indexed for MEDLINE]
7.

Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells.

Zhu H, Liu Z, Tang L, Liu J, Zhou M, Xie F, Wang Z, Wang Y, Shen S, Hu L, Yu L.

Eur J Pharmacol. 2012 Dec 5;696(1-3):43-53. doi: 10.1016/j.ejphar.2012.09.046. Epub 2012 Oct 7.

PMID:
23051672
[PubMed - indexed for MEDLINE]
8.

Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance.

Chanmahasathien W, Ampasavate C, Greger H, Limtrakul P.

Phytomedicine. 2011 Jan 15;18(2-3):199-204. doi: 10.1016/j.phymed.2010.07.014. Epub 2010 Aug 24.

PMID:
20739156
[PubMed - indexed for MEDLINE]
9.

Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.

Jovelet C, Bénard J, Forestier F, Farinotti R, Bidart JM, Gil S.

Eur J Pharm Sci. 2012 Aug 15;46(5):484-91. doi: 10.1016/j.ejps.2012.03.012. Epub 2012 Mar 30.

PMID:
22484209
[PubMed - indexed for MEDLINE]
10.

Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.

Lavie Y, Harel-Orbital T, Gaffield W, Liscovitch M.

Anticancer Res. 2001 Mar-Apr;21(2A):1189-94.

PMID:
11396162
[PubMed - indexed for MEDLINE]
11.

Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells.

Eid SY, El-Readi MZ, Eldin EE, Fatani SH, Wink M.

Phytomedicine. 2013 Dec 15;21(1):47-61. doi: 10.1016/j.phymed.2013.07.019. Epub 2013 Aug 30.

PMID:
23999162
[PubMed - indexed for MEDLINE]
12.

Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.

Limtrakul P, Siwanon S, Yodkeeree S, Duangrat C.

Phytomedicine. 2007 Jun;14(6):381-9. Epub 2007 Apr 30.

PMID:
17467965
[PubMed - indexed for MEDLINE]
13.

8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1.

Wesołowska O, Wiśniewski J, Sroda K, Krawczenko A, Bielawska-Pohl A, Paprocka M, Duś D, Michalak K.

Eur J Pharmacol. 2010 Oct 10;644(1-3):32-40. doi: 10.1016/j.ejphar.2010.06.069. Epub 2010 Jul 13.

PMID:
20633549
[PubMed - indexed for MEDLINE]
14.

Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.

Smith CD, Myers CB, Zilfou JT, Smith SN, Lawrence DS.

Oncol Res. 2000;12(5):219-29.

PMID:
11417747
[PubMed - indexed for MEDLINE]
15.

Microparticles and their emerging role in cancer multidrug resistance.

Gong J, Jaiswal R, Mathys JM, Combes V, Grau GE, Bebawy M.

Cancer Treat Rev. 2012 May;38(3):226-34. doi: 10.1016/j.ctrv.2011.06.005. Epub 2011 Jul 14. Review.

PMID:
21757296
[PubMed - indexed for MEDLINE]
16.

Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.

de Jong MC, Scheffer GL, Broxterman HJ, Hooijberg JH, Slootstra JW, Meloen RH, Kreitman RJ, Husain SR, Joshi BH, Puri RK, Scheper RJ.

Clin Cancer Res. 2003 Oct 15;9(13):5009-17.

PMID:
14581376
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells.

Rothweiler F, Michaelis M, Brauer P, Otte J, Weber K, Fehse B, Doerr HW, Wiese M, Kreuter J, Al-Abed Y, Nicoletti F, Cinatl J Jr.

Neoplasia. 2010 Dec;12(12):1023-30.

PMID:
21170266
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.

Wang TH, Wan JY, Gong X, Li HZ, Cheng Y.

Oncol Rep. 2012 Nov;28(5):1681-6. doi: 10.3892/or.2012.1999. Epub 2012 Aug 30.

PMID:
22941407
[PubMed - indexed for MEDLINE]
20.

The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP.

Sun S, Chen Z, Li L, Sun D, Tian Y, Pan H, Bi H, Huang M, Zeng S, Jiang H.

Xenobiotica. 2012 Dec;42(12):1197-205. doi: 10.3109/00498254.2012.702247. Epub 2012 Aug 19.

PMID:
22900779
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk